Healthcare
iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue
iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue
Net loss narrowing to $2.1m, compared with a loss of $6.3m in 1H FY 2025.
4 hours ago
Singapore Paincare expands operations and client base with TS Medical acquisition
The SGX-listed group acquired 51% of the company which operates Doctors for Life Medical.
3 days ago
Precision for Medicine widens APAC reach with new Singapore office
The new office will serve as its APAC hub for biomarker research.
3 days ago
SMART and NUS weaponize AI to give soft robots human-like reflexes
The system reduced tracking error by 44% to 55% under heavy disturbances.
4 days ago
AJJ, Huaxi unveil eldercare robot roadmap after HSA milestone
Robot clears HSA Class A device notification.
NTU, Gu Sheng Tang push TCM research with $1.06m programme
Visiting experts from China will provide clinical mentorship for local practitioners.
$45b state surge triggers global VC influx to Singapore’s Biopolis
The 2% GDP spend on R&D served as a talent magnet for returning overseas scientists.
HSA clears cancer-detecting AI for routine hospital use
Intelligent Scopes Corp secures regulatory green light for its new bladder cancer software.
Health Information Bill compels providers to share patient data
The new bill is expected to take effect in early 2027.
Cordlife renews cord blood and human tissue banking licences
Conditions were set specifically for its cord blood banking permit.
Tong Kooi Ong replaces Ng Ser Miang as Thomson chair
The leadership change takes effect 1 February following Ng Ser Miang’s resignation.
Singapore Paincare reports $3.74m net loss in FY2025
Company revenue drops 3.5% to $25.97m in FY2025.
SMART launches project researching wearable ultrasound system for elderly care
MIT, Singapore partners project invests millions on groundbreaking health tech innovation
Singapore-led medtech initiative brings artificial-heart device to Indonesia
The device targets Indonesia’s heart-failure gap with a smaller, lighter design backed by Singapore.
IHH Healthcare’s profit rises 15% to $193.66m in Q3
Higher daycare and medical tourism supported the quarterly PATMI growth.
MOH scraps full-deductible IP riders from 2026
This is amidst low employer healthcare spending and a growing insurance market.
Singapore–Malaysia medtech pilot seen luring more regional investment
Participation would still hinge on market opportunity and product demand.
Read Here
Advertise
Sign Up
Commentary
Singapore’s family offices: Time to professionalise or risk falling behind
Liquidity crucial to stock market reform